Partnering
Home » Partnering
PARTNER WITH US TO ACCELERATE
YOUR ANTIBODY PROGRAM
YUMAB is driven by continuous research innovation and long-standing expertise, powerful technology platforms, and collaborative teamwork. As privately held company we can offer highly flexible and tailored solution-oriented options for our clients and partners.
Ways to partner with us:
contract research & services
We offer tailored, royalty-free contract research for the discovery and development of human and humanized antibody therapeutics, from engineering to validation.
Partnered research
Enhance affinity, stability, and functionality with AI-assisted optimization.
Collaboration
Together with top academic and industry partners, we drive technology innovation and fast-track novel biotherapeutics into the clinic.
licensing
Our proprietary platform technologies and assets are available for licensing.
FTE-based Research
Prepaid FTE-based contract research to access our expertise and platforms for extending your R&D capacities.
How do we drive your innovation?
Scientific & Eechnological
Expertise
YUMAB has over 35 years of scientific expertise in pioneering antibody technologies and more than 14 years of industrial experience, with over 650 successfully completed research projects.
Powerful Technology Platforms
We leverage advanced antibody technologies—from target to lead—powered by AI, experimental engineering, and a robust partner network to maximize their potential.
Science Driven & Collaborative Teamwork
Tailored project plans provide maximum flexibility in R&D, while our expert team designs optimal strategies for discovery, selection, and lead optimization to deliver next-generation biotherapeutic candidates.
Efficient & Flexible Project Management
We de-risk antibody programs by identifying and addressing sequence liabilities and suboptimal properties early in the process, helping to avoid delays, reduce costs, and safeguard later stages of development.
Fair Financial Conditions
We operate with fair and transparent financial terms. Our services are royalty-free, free from extra third-party licenses, and we connect you with partners offering equitable conditions. For our French clients: Contract research is eligible for the CIR tax credit.
YUMAB Ecosystem
We build on reliable partners
YUMAB’s continued growth is fueled by a large and reliable network of international partners, providing additional technologies and services that are seamlessly integrated into our research. Collaborating with other technology experts enables us to deliver superior research, rather than offering mediocre one-stop-shop solutions.
Our partners also support our ongoing internal technology innovation, either through funding or joint technology collaborations. Become a YUMAB partner and benefit from our collaborative spirit.
YUMAB and InSCREENeX get funding for innovative Mammalian Display screening – Yumab
Plattform für die Entwicklung von
T-Zellrezeptor ähnlichen bispezifischen
T-Zellaktivatoren mit hohem Sicherheitsprofil zur Krebsbehandlung (safeTY-engager) – Entwicklung der Antikörperformate